跳至主要内容
临床试验/EUCTR2021-006953-77-DK
EUCTR2021-006953-77-DK进行中(未招募)1 期

Treatment effects of Bisoprolol and Verapamil in symptomatic patients with non-obstructive hypertrophic cardiomyopathy - TEMPO II

Aarhus University Hospital0 个研究点目标入组 140 人开始时间: 2022年1月31日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Informed consent
  • - Age = 18 years
  • - Maximal wall thickness = 15 mm unrelated to hypertension, valve diseases or storage diseases.
  • - And one of the following:
  • 1.New York Heart Association – functional class (NYHA) = II
  • 2.A history of NYHA class = II before treatment with BB or CCB
  • 3.pro-BNP>300 ng/l/35>nmol/l or BNP >100ng/l/>29nmol/l
  • 4.Non-sustained VT (>120 min-1, =3 cycles) documented within the last 2 years of screening
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 40

排除标准

  • - Left ventricular ejection fraction < 50%
  • - LVOT gradient >30 mmHg at rest or during Valsalva maneuver after discontinuation of BB or CCB respectively
  • - Previous history of LVOT gradient >30 mmHg at rest, during exercise or during Valsalva maneuver.
  • - Permanent atrial fibrillation
  • - Permanent right ventricular pacing
  • - Previous intolerance for Bisoprolol (BB) or Verapamil (CCB)
  • - Known present obstructive coronary disease (previous percutaneous coronary intervention is accepted)
  • - eGFR < 40 ml/min
  • - Fertile women (<50 years) who are pregnant (Positive Plasma-HCG), breastfeeding or not using anticonceptions.
  • - Significant liver failure, severe valvular disease, bradycardia (40bpm) or hypotension (systolic <100mmHg), other significant comorbidity or risks associated with discontinuation of BB or CCB after individual judgement by the investigators.
  • - Unable to understand patient information intellectually or linguistically
  • - Unable to perform exercise test.
  • - Unable to speak and/or understand Danish.
  • Additional exclusion criteria for CMRI sub-study:
  • - Implantable cardioverter defibrillator (any kind)
  • - Pacemaker (any kind)
  • - Metal implants like to affect image quality
  • - Metal implants that poses a risk during CMR
  • - Inability to cope with being in the scanner.

研究者

发起方
Aarhus University Hospital

相似试验